论文部分内容阅读
目的观察探讨他汀类降脂药物治疗冠心病的临床疗效,总结其临床应用价值及临床经验。方法选取我院2009年9月至2011年9月70例冠心病的患者,随机分为观察组与对照组,各35例,皆采取常规治疗,对照组在常规治疗基础上使用阿司匹林治疗,观察组在常规治疗基础上使用他汀类药物治疗,观察对比两组治疗效果。结果观察组的总有效率94.3%(33/35);对照组的总有效率80.0%(28/35),观察组和对照组的临床疗效对比有明显的差异(X2=9.13,P<0.01),具有统计学意义。结论采取他汀类降脂药物治疗冠心病疗效显著,优于传统使用阿司匹林治疗,可以有助于改善心绞痛症状,同时能够有效预防心脑血管事件发生,安全可靠,值得临床合理推广。
Objective To investigate the clinical efficacy of statins lipid-lowering drugs in the treatment of coronary heart disease and to summarize its clinical value and clinical experience. Methods Seventy patients with coronary heart disease in our hospital from September 2009 to September 2011 were randomly divided into observation group and control group, 35 cases in each group. All patients in the control group were treated with conventional therapy. The patients in the control group were treated with aspirin on the basis of routine treatment. Group on the basis of conventional treatment using statins, the treatment was observed and compared two groups. Results The total effective rate in the observation group was 94.3% (33/35). The total effective rate in the control group was 80.0% (28/35). There was significant difference between the observation group and the control group (X2 = 9.13, P <0.01) ),has statistical significane. Conclusion Statin lipid-lowering drugs are effective in treating coronary heart disease, which is superior to the traditional aspirin treatment. It can help improve the symptoms of angina pectoris, and can effectively prevent the occurrence of cardiovascular and cerebrovascular events. It is safe and reliable and worthy of clinical promotion.